Ophthalmology Therapeutics Market by Indication (Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis) by End User (Hospitals, Eye Clinics, Diagnostic Centres and Patients), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Ophthalmology Therapeutics Market by Indication (Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis) by End User (Hospitals, Eye Clinics, Diagnostic Centres and Patients), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1106 | Pages: 184 | November 2016 | Region: Global


The Global Ophthalmology Therapeutics Market was worth $22.3 billion in 2016 and estimated to be growing at a CAGR of 7.4%, to reach $31.87 billion by 2021. The market is showcasing evident potential in the mentioned forecasting period. Ophthalmology is the branch of medicine associated with the treatment of eye defects and diseases. With the recent advancements in genetics and stem cell biology, the mechanisms of many ophthalmic diseases are being revealed progressively.

Global market for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment, which was estimated to be 147 million in 2010, and is estimated to reach 191 million in the world in 2020. Technological advancement in the field of medicine are also playing a major role in the growth of the market. Increasing geriatric population around the globe along with rise in disposable income are some of the other factors driving the market for Ophthalmology Therapeutics Market. However, lack of awareness about the various diseases associated with ophthalmology is a major factor restraining the growth of the market. Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for market growth.

The Global market for Ophthalmology Therapeutics is broadly categorized into Indication and End User. On the basis of indication global Ophthalmology Therapeutics market is segmented into Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately 31% followed by AMD with a share of 27%. Based on end User the market is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients.

On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East. North America is the dominating market for Ophthalmology Therapeutics accounting for a share of approximately xx% followed by Europe. Asia-Pacific is estimated to be the fastest growing region with a CAGR of xx% during the forecast period of 2016-2021.

Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc. and Roche are the major companies in the market accounting for a share of approximately 70%. Other major companies covered in the report are Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Indication                              

                                5.1.1 Glaucoma

                                5.1.2 Dry Eye Syndrome

                                5.1.3 Diabetic Retinopathy         

                                5.1.4 Retinal Vein Occlusion        

                                5.1.5 Age-Related Macular Degeneration (AMD)

                                5.1.6 Macular Edema    

                                5.1.7 Allergic Conjunctivitis         

                5.2 By End User               

                                5.2.1 Hospitals  

                                5.2.2 Eye Clinics

                                5.2.3 Diagnostic Centers              

                                5.2.4 Patients   

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Allergan, Inc.                              

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck & Co Inc                         

                9.3 Pfizer                            

                9.4 Roche                           

                9.5 Novartis (Alcon)                       

                9.6 Valeant                        

                9.7 Regeneron                 

                9.8 Santen                         

                9.9 Bayer                            

                9.10 Senju                          

                9.11 Lpath                          

                9.12 Eye Gate Pharmaceuticals                 

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  2. Global Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  3. Global Glaucoma Market By Region, From 2016-2021 (USD Billion)
  4. Global Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  5. Global Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  6. Global Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  7. Global Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  8. Global Macular Edema Market By Region, From 2016-2021 (USD Billion)
  9. Global Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  10. Global Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  11. Global Hospitals Market By Region, From 2016-2021 (USD Billion)
  12. Global Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  13. Global Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  14. Global Patients Market By Region, From 2016-2021 (USD Billion)
  15. North America Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  16. North America Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  17. North America Glaucoma Market By Region, From 2016-2021 (USD Billion)
  18. North America Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  19. North America Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  20. North America Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  21. North America Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  22. North America Macular Edema Market By Region, From 2016-2021 (USD Billion)
  23. North America Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  24. North America Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  25. North America Hospitals Market By Region, From 2016-2021 (USD Billion)
  26. North America Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  27. North America Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  28. North America Patients Market By Region, From 2016-2021 (USD Billion)
  29. United States Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  30. United States Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  31. Canada Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  32. Canada Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  33. Europe Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  34. Europe Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  35. Europe Glaucoma Market By Region, From 2016-2021 (USD Billion)
  36. Europe Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  37. Europe Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  38. Europe Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  39. Europe Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  40. Europe Macular Edema Market By Region, From 2016-2021 (USD Billion)
  41. Europe Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  42. Europe Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  43. Europe Hospitals Market By Region, From 2016-2021 (USD Billion)
  44. Europe Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  45. Europe Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  46. Europe Patients Market By Region, From 2016-2021 (USD Billion)
  47. U.K Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  48. U.K Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  49. Spain Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  50. Spain Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  51. Germany Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  52. Germany Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  53. Italy Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  54. Italy Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  55. France Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  56. France Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  57. Asia-Pacific Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  58. Asia-Pacific Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  59. Asia-Pacific Glaucoma Market By Region, From 2016-2021 (USD Billion)
  60. Asia-Pacific Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  61. Asia-Pacific Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  62. Asia-Pacific Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  63. Asia-Pacific Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  64. Asia-Pacific Macular Edema Market By Region, From 2016-2021 (USD Billion)
  65. Asia-Pacific Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  66. Asia-Pacific Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  67. Asia-Pacific Hospitals Market By Region, From 2016-2021 (USD Billion)
  68. Asia-Pacific Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  69. Asia-Pacific Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  70. Asia-Pacific Patients Market By Region, From 2016-2021 (USD Billion)
  71. China Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  72. China Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  73. India Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  74. India Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  75. Japan Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  76. Japan Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  77. South Korea Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  78. South Korea Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  79. Australia Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  80. Australia Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  81. Latin America Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  82. Latin America Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  83. Latin America Glaucoma Market By Region, From 2016-2021 (USD Billion)
  84. Latin America Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  85. Latin America Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  86. Latin America Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  87. Latin America Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  88. Latin America Macular Edema Market By Region, From 2016-2021 (USD Billion)
  89. Latin America Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  90. Latin America Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  91. Latin America Hospitals Market By Region, From 2016-2021 (USD Billion)
  92. Latin America Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  93. Latin America Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  94. Latin America Patients Market By Region, From 2016-2021 (USD Billion)
  95. Brazil Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  96. Brazil Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  97. Argentina Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  98. Argentina Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  99. Mexico Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  100. Mexico Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  101. Middle East & Africa Ophthalmology Therapeutics Market By Region, From 2016-2021 (USD Billion)
  102. Middle East & Africa Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  103. Middle East & Africa Glaucoma Market By Region, From 2016-2021 (USD Billion)
  104. Middle East & Africa Dry Eye Syndrome Market By Region, From 2016-2021 (USD Billion)
  105. Middle East & Africa Diabetic Retinopathy Market By Region, From 2016-2021 (USD Billion)
  106. Middle East & Africa Retinal Vein Occlusion Market By Region, From 2016-2021 (USD Billion)
  107. Middle East & Africa Age-Related Macular Degeneration (AMD) Market By Region, From 2016-2021 (USD Billion)
  108. Middle East & Africa Macular Edema Market By Region, From 2016-2021 (USD Billion)
  109. Middle East & Africa Allergic Conjunctivitis Market By Region, From 2016-2021 (USD Billion)
  110. Middle East & Africa Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  111. Middle East & Africa Hospitals Market By Region, From 2016-2021 (USD Billion)
  112. Middle East & Africa Eye Clinics Market By Region, From 2016-2021 (USD Billion)
  113. Middle East & Africa Diagnostic Centers Market By Region, From 2016-2021 (USD Billion)
  114. Middle East & Africa Patients Market By Region, From 2016-2021 (USD Billion)
  115. Middle East Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  116. Middle East Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
  117. Africa Ophthalmology Therapeutics Market By Indication, From 2016-2021 (USD Billion)
  118. Africa Ophthalmology Therapeutics Market By End-User, From 2016-2021 (USD Billion)
Middle East And Africa Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiol...
Latin America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Asia Pacific Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Moo...
Europe Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stab...
North America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers...
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.